quinaldic acid has been researched along with Colonic Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jeleniewicz, W; Langner, E; Plech, T; Turski, WA | 1 |
| Jeleniewicz, W; Langner, E; Rajtar, G; Turski, WA; Walczak, K | 1 |
2 other study(ies) available for quinaldic acid and Colonic Neoplasms
| Article | Year |
|---|---|
Quinaldic acid induces changes in the expression of p53 tumor suppressor both on protein and gene level in colon cancer LS180 cells.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Gene Expression Regulation, Neoplastic; Gene Silencing; Humans; Quinolines; Real-Time Polymerase Chain Reaction; RNA, Small Interfering; Tumor Suppressor Protein p53 | 2019 |
Quinaldic acid inhibits proliferation of colon cancer ht-29 cells in vitro: effects on signaling pathways.
Topics: Antineoplastic Agents; Cell Proliferation; Colonic Neoplasms; Cyclic AMP Response Element-Binding Protein; Gene Expression Regulation, Neoplastic; HT29 Cells; Humans; Mitogen-Activated Protein Kinases; Phosphorylation; Quinolines; Signal Transduction | 2015 |